4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-23-040615
Options or other derivatives
- Chief Financial Officer acquired 432,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Musso Alan A · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-07 | Grant or award : show line 1 in the form Stock Option (right to buy) | +432,800 | 432,800 | D |
Loading xslF345X05/ownership.xml…